We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deepmatter Group Plc | LSE:DMTR | London | Ordinary Share | GB00B29YYY86 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0325 | 0.025 | 0.04 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/12/2020 15:33 | Halfpenny sounds like a short? | deutsch4 | |
08/12/2020 10:24 | DMTR expecting a breakthrough RNS soon. Get ready for the rapid rise. RSI AT A GREAT LEVEL.. | halfpenny | |
08/12/2020 09:56 | I bet you’re great at just a minute. | yump | |
08/12/2020 09:23 | Thats exactly how it works. People can look at your youtube and write up and easily reproduce it. Just like the people who fix their own bikes by watching someone else’s excellent video and then bring it to me because their chain has gone off into the spokes and mangled the derailleur. DMTR is all about reliable reproduceability, particularly with critical research. Thats why some big players are on the same route. But of course half the comments on here are from people who aren’t really interested in researching businesses. | yump | |
08/12/2020 07:52 | And also Stig the Digital Glassware is like me mixing some chemicals in a lab beaker, sticking a thermometer, recording the process with my phone camera onto youtube and writing up the experiment. It is something that every lab tech does anyway. I am struggling to see any difference or a unique commercial angle. | notconvinced | |
07/12/2020 22:28 | I'm expecting this coiled spring to go rapidly in the upward direction at little or no notice, which would make buying very tricky or impossible. I totally agree with McCrud that the best strategy is to buy and hold, sitting tight, and not be dissuaded by the obvious village idiot on this bb. GLA JP | jpuff | |
07/12/2020 16:42 | Not much evidence of industry workers buying into this. If it's that good it is a well kept secret? - It seems as if "I wouldn't give tuppence" is the sentiment? | deutsch4 | |
07/12/2020 15:44 | Sit tight and wait, ignoring the resident multi Id poster who thinks it's a glorified test tube lolThat's why cancer research, AstraZeneca, Novartis and more all want a slice. Must be a shortage of test tubes lol | mcrudden | |
07/12/2020 12:17 | DMTR visiting a company using these products will see how enthusiastic customers are and ALL wanting more. Roadmap of products are great. A strong foundation forming and with further news flow sky is the limit. Great management team waiting for RNS soon... | halfpenny | |
30/11/2020 16:31 | Socialism - provide a service without charge - Dreamers! | deutsch4 | |
30/11/2020 15:11 | No I thought they had something Stig, they may still have, but these tools already exist, so how they can differentiate will be the key to whether they make it or not. | notconvinced | |
30/11/2020 14:32 | It's just a glorified test tubes supplier. Valuation is nuts. The fact they have to give it away free is the big giveaway. | the stigologist | |
30/11/2020 13:54 | I thought with the COVID distancing rules that Deep Matter cloud based chemistry would be the muts nuts for the industry, but a Uni buddy who works as an ASC at Veristat says a lot of the tools and software used are open source or developed in house, and it has been that way for years. After the Icsynth announcement I expected Deep Matter to power on, but it may be the target user group already have the tools they need? | notconvinced | |
19/11/2020 16:28 | Have to agree also, | mcrudden | |
19/11/2020 16:26 | I agree with the positive sentiments here. Just buy at these bargain levels whilst under the radar and hold. It'll move too quick to buy in once it gets going. Imho | jpuff | |
19/11/2020 14:11 | me-thinks we can't go any deeper. | deutsch4 | |
19/11/2020 12:19 | City Analyst1, i agree/correct and i am extremely positive on DMTR with lots of great and exiting potential. News flow in the pipeline....this is one of those rare finds in the market...can explode vey quickly once analysts did Deeper as its a no brainer!!! | halfpenny | |
19/11/2020 05:04 | Jl123US, as Halfpenny aptly puts it, Karen Bach is the 'game changer' at DMTR. Just take a look at her accomplishments at Amino Technologies and Datapharm. Incredible! And if you're wondering, why now? Well, listen to the company's head honcho, Mark Warne: "The new recruits (Bach and Benson) would bring valuable skills and experience as the company looks to scale-up and to enter new territories. We now have the products to help revolutionise the global drug development process." Nathan Collins, the Chief Approach Officer of SRI Biosciences, puts it even better: “The overwhelming majority of chemistry hasn’t modified (from the way it develops drugs) in 200 years! The 'chemputer' will change all that. Using scientific innovation and automation to speed-up drug discovery timelines is nothing short of groundbreaking.̶ So Jl123US, from where I'm sitting, this now appears to be a highly disruptive and transformational business with substantive growth prospects. More importantly though, it's gaining traction at a staggering pace. And because of this, I'm in. AIMHO. . | city analyst1 | |
18/11/2020 10:20 | DMTR now has a game changer ie Karen Bach brings significant public and private technology expertise, this should provide fuel to the drive upwards and onwards. 3++ soon and she will buy more shares. Get ready as it can move up very quickly..3+++ | halfpenny | |
17/11/2020 23:16 | Piddler? Is that in reference to riddler who posts on Twitter? Some of his ramping on Twitter is shameful bordering on misinformation, but this company looks like it has potential to be fair. | jl123us | |
17/11/2020 23:05 | The graph dear boy...looks like a U boat on manoeuvres...only the periscope above 2p. | deutsch4 | |
16/11/2020 13:34 | More folk doing proper research now judging by the rise and bargain entry level. Dyor as ever. GLA | jpuff | |
16/11/2020 11:43 | Still here waiting for tim nice but dim to pop up as we rise again... how's the trading stig, tough work if you don't research isn't it | mcrudden |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions